Urological Society for
American Veterans

2023 USAV Annual Meeting (during the AUA Annual Meeting)
Chicago  - Sunday, April 30, 10:30am to 2:30pm

Hyatt Regency McCormick Place - Regency Ballroom CDE

2023 Program Highlights:

  • Pathways to fund your research at VA
  • Theranostics in Prostate Cancer
  • Establishing Male Infertility  Program in VA: tips and tricks
  • Disposable ureteroscopes: Are they worth it?
  • Lunch Included - must RSVP for ticket

USAV MEETING CHICAGO - DETAILED SCHEDULE  (REV MAR 1, 2023)
Sunday, April 30, 2023, 10:00 AM - 2:30 PM
Hyatt Regency McCormick Place
Regency Ballroom CDE

TIME PRESENTATION SPEAKER
10:00 AM Check-in / Exhibit set up / Network with Physicians
10:30 AM Welcome / USAV Update Robert L. Grubb III, MD, President, Medical University of South Carolina, Ralph H. Johnson VA Medical Center    /             Abhinav Sidana, MD, Scientific Program Chair, University of Cincinnati College of Medicine
10:35 AM Pathways to fund your research in the Veterans Health Administration. Ted Skolarus, MD, MPH, FACS,
University of Chicago, VA Ann Arbor Healthcare System
10:55 AM Establishing Male Infertility  Program in VA: tips and tricks. Sarah C. Krzastek, MD, Central Virginia VA Health Care System
11:15 AM Disposable ureteroscopes: Are they worth it? Bodo E. Knudsen, MD, Ohio State Univ. Wexner Med. Ctr.
11:35 AM Sponsor highlights (1 slide each)
11:45 AM Lunch Break /review Posters/ Visit Exhibits
PAPER ID# Viewing of Unmoderated Posters Moderator: Sudhir Isharwal, MD
#06 Postoperative PSA testing after radical prostatectomy: when should the initial PSA be obtained? Emily Fisher, (3rd year Med. Student)
#07 Examining the Utility of an Exosome-Based Urine Test in Prostate Cancer Screening in a Veteran Population. Sarah C. Krzastek, MD
#08 Physical Activity, Frailty, and Functional Outcomes in Men undergoing Androgen Deprivation Therapy. Aubrey K. Jarman, BS, RD
#09 Management of Patients that do not Achieve an Undetectable PSA After Prostatectomy. Dennis Boynton, BS
#10 Race, geography, and prostate cancer outcomes in patients treated in the VA Health Care System. Ivy T. Liu BS
#11 Using the Femoral Head Size to Determine Prostate Volume from Cross-sectional Imaging. Samuel J. Han
#12 The association between C-reactive protein levels and prostate cancer recurrence in nonmetastatic radical prostatectomy patients. Ieva Juzumaite, BA
#13 Negative PSA Velocity and Its Impact on Patients With Elevated PSA. Alexander H. Fang, BS
#14 Preferences for interventions to address unmet sexual health information and support needs among female partners of men with prostate cancer. Natasha Gupta, MD
#15 The histopathological basis of false positive PI-RADS 4/5 lesions. Nilesh Patil, MD
#16 Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from Shared Equal Access Regional Cancer Hospital (SEARCH). Lourdes Guerrios-Rivera, MD
#18 Extreme-Low-Dose (XLD) Intraoperative CT scan (ICT) (<0.5 mSv) Achieved During Percutaneous Stone Treatments using a Robotic Multiplanar Fluoroscopy Systems (RMPFS) Brett M. Wiesen, MD
12:55 PM Industry Supported Talk during Lunch - TBD
1:15 PM Podium Presentations - 4 min each / 5 slides Moderator: Thomas A. Masterson, MD
PAPER ID# TITLE PRESENTER
#01 Survival Comparison of Inflatable Penile Prosthesis Placement at a Veterans Affairs Medical Center Compared to A Tertiary Referral Center. Parth Thakker, MD
#02 Variances in pathologic findings at biopsy in equal access Veteran’s Administration Hospital following the 2018 USPSTF PSA screening recommendations. Karl-Ray O. Jeune, BA
#03 Prostate Biopsy Sepsis Prevention: External Validation of an Isopropyl Alcohol Needle
Washing Protocol.
Anthony Hiffa, MD, MPH
#04 Representation Matters for Black Patients with Prostate Cancer: Qualitative Study of Digital Information. Stacy Loeb, MD, MSc, PhD
#05 Accurate Documentation Contributes to Guideline Concordant Surveillance of Non-Muscle Invasive Bladder Cancer: a Multi-site VA Study. Vikram Lyall, MD
#17 Changes in Serial Decipher Genomic Classifier Testing Among Patients with Prostate Cancer Managed with Active Surveillance. Ghazal Khajir, MD
1:50 PM Active Surveillance 2.0: Impact of MRI and biomarkers on surveillance strategy. Stacy Loeb, MD, MSc, PhD, NYU Lagone Health and Manhattan Veterans Affairs
2:10 PM NSO Update. Jeremy Shelton, MD
2:15 PM Awards / Prize Drawings Abhinav Sidana, MD / Robert Grubb, MD
2:30 PM End of Meeting

 

We gratefully acknowledge these exhibiting companies for supporting our 2022 meeting!

PLATINUM SUPPORTERS: EXACT SCIENCES • PROCEPT BIOROBOTICS
GOLD SUPPORTERS:  EXOSOME DIAGNOSTICS • GUERBET •  KARL STORZ ENDOSCOPY
SILVER SUPPORTERS:  DECIPHER UROLOGIC CANCERS •  BK MEDICAL • PACIFIC EDGE DIAGNOSTICS • PHOTOCURE • LANTHEUS •  TELEFLEX .....................................SONABLATE CORP  •  WELLSPECT HEALTHCARE